OTC Markets OTCQB - Delayed Quote USD

Pharma-Bio Serv, Inc. (PBSV)

Compare
0.5300
+0.1190
+(28.95%)
At close: January 13 at 9:50:07 AM EST

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Victor Sanchez CEO, President & President of European Operations 323.67k -- 1971
Mr. Pedro J. Lasanta CFO, VP of Finance & Administration and Secretary 225.6k -- 1960
Ms. Elizabeth Plaza Founder & Senior Strategic Consultant 69.92k -- 1964
Ms. Miriam Marrero M.B.A. Human Resources Manager -- -- --

Pharma-Bio Serv, Inc.

Pharma-Bio Serv Building
Suite 6 Road 696
Dorado, PR 00646
United States
787 278 2709 https://www.pharmabioserv.com
Sector: 
Healthcare
Full Time Employees: 
100

Description

Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. Pharma-Bio Serv, Inc. was founded in 1993 and is headquartered in Dorado, Puerto Rico.

Corporate Governance

Pharma-Bio Serv, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

January 27, 2025 at 9:00 PM UTC - January 31, 2025 at 9:00 PM UTC

Pharma-Bio Serv, Inc. Earnings Date

Recent Events

September 16, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

June 14, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

May 2, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

April 8, 2024 at 12:00 AM UTC

DEF 14A: Proxy Statements

March 18, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

February 28, 2024 at 12:00 AM UTC

10-K/A: Periodic Financial Reports

February 15, 2024 at 12:00 AM UTC

Dividend Date

January 30, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

January 29, 2024 at 12:00 AM UTC

10-K: Periodic Financial Reports

January 29, 2024 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers